Psoriatic arthritis: A clinical entity distinct from psoriasis?

Revista Brasileira de Reumatologia

Volumn 52, Issue 4, 2012, Pages 630-638

  Ruiz, Danilo Garcia ^a,b   de Azevedo, Mário Newton Leitão ^a   da Rosa Santos, Omar Lupi ^a,c,d  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b Porto Nacional   (Brazil)

^c FEDERAL UNIVERSITY OF THE STATE OF RIO DE JANEIRO   (Brazil)

^d Instituto Carlos Chagas   (Brazil)

Author keywords

Interrelation; Psoriasis; Psoriatic arthritis

Indexed keywords

ANTIMALARIAL AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; HLA ANTIGEN; HLA B ANTIGEN; HLA B13 ANTIGEN; HLA B17 ANTIGEN; HLA B27 ANTIGEN; HLA B37 ANTIGEN; HLA BW16 ANTIGEN; HLA BW57 ANTIGEN; HLA CW6 ANTIGEN; HLA DR7 ANTIGEN; INTERFERON; LITHIUM CARBONATE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL FEATURE; COMORBIDITY; CORTICOSTEROID THERAPY; DACTYLITIS; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; ENTHESITIS; ENVIRONMENTAL FACTOR; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; HEALTH CARE COST; HIGH RISK POPULATION; HLA SYSTEM; HUMAN; IMMUNOPATHOGENESIS; INCIDENCE; LEPROSY; NAIL PSORIASIS; PREVALENCE; PSORIASIS; PSORIATIC ARTHRITIS; QUALITY OF LIFE; SPONDYLOARTHROPATHY; T LYMPHOCYTE;

ARTHRITIS, PSORIATIC; DIAGNOSIS, DIFFERENTIAL; HUMANS; PSORIASIS;

EID: 84866484263     PISSN: 04825004     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0482-50042012000400012     Document Type: Article

References (51)

1. Griffiths CEM, Barker JN. Pathogenesis and clinical features of psoriasis. Lancet 2007; 370(9583):263-71.
2. Moll JM, Wright V. Psoriatic arthritis. Semin Arthritis Rheum 1973; 3(1):55-78.
3. a ed. São Paulo: McGraw-Hill, 2008.
4. Scarpa R, Ayala F, Caporaso N, Olivieri I. Psoriasis, psoriatic arthritis, or psoriatic disease? J Rheumatol 2006; 33(2):210-1
5. Van de Kerkhof PCM, Schalkwijk J. Psoriasis. In: Bolognia JL, Jorizzo JL, Rapini RP. Dermatology. 2.ed. Espanha: Elsevier, 2008.
6. Bruce IN. Psoriatic arthritis: clinical features. In: Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH. Rheumatology. 4.ed. Philadelphia: Elsevier, 2008.
7. Blumberg BS, Bunim JJ, Calkins E, Pirani CL, Zvaifler NJ. ARA nomenclature and classification of arthritis and rheumatism (tentative). Arthritis Rheum 1964; 7:93-7.
8. Gudjonsson JE, Elder JT. Psoriasis: epidemiology. Clin Dermatol 2007; 25(6):535-46.
9. Shao CG, Zhang GW, Wang GC. Distribution of psoriasis in China: a nationwide screening. Proc Chin Acad Med Sci Peking Union Med Coll 1987; 2(2):59-65.
10. th Congress on Dermatology. Amsterdam: Excerpta Medica, 1962; p. 196.
11. Huerta C, Rivero E, Rodríguez LA. Incidence and risk factors for psoriasis in the general population. Arch Dermatol 2007; 143(12):1559-65.
12. Gelfand JM, Gladman DD, Mease PJ, Smith N, Margolis DJ, Nijsten T et al. Epidemiology of psoriatic arthritis in the population of United States. J Am Acad Dermatol 2005; 53(4):573.
13. Gisondi P, Girolomoni G, Sampogna F, Tabolli S, Abeni D. Prevalence of psoriatic arthritis and joint complaints in a large population of Italian patients hospitalised for psoriais. Eur J Dermatol 2005; 15(4):279-83.
14. Njobvu P, McGill P, Kerr H, Jellis J, Pobee J. Spondyloarthropathy and human immunodeficiency virus infection in Zambia. J Rheumatol 1998; 25(8):1553-9.
15. Njobvu P, McGill P. Psoriatic arthritis and human immunodeficiency virus infection in Zambia. J Rheumatol 2000; 27(7):1699-702.
16. Schur PH. Artrite psoriásica e artrite associada a doenças gastrointestinais. In: Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL. Harrison - Medicina Interna. 15.ed. Rio de Janeiro: McGrawHill, 2002; p. 2125-7.
17. Zachariae H, Zachariae R, Blomqvist K, Davidsson S, Molin L, Mørk C, et al. Quality of life and prevalence of arthritis reported by 5,795 members of the Nordic Psoriasis Association. Acta Derm Venereol 2002; 82(2):108-13.
18. Fortune DG, Richards HL, Main CJ, Griffiths CEM. What patients with psoriasis believe about their condition. J Am Acad Dermatol 1998; 39(2 Pt 1):196-201.
19. Myers WA, Gottlieb AB, Mease P. Psoriasis and psoriatic arthritis: clinical features and disease mechanisms. Clin Dermatol 2006; 24(5):438-47.
20. Chandran V, Schentag CJ, Brockbank JE, Pellett FJ, Shanmugarajah S, Toloza SM et al. Familial aggregation of psoriatic arthritis. Ann Rheum Dis 2009; 68(5):664-7.
21. Fitzpatrick TB, Johnson RA, Wolff K, Suurmond D. Dermatologia - Atlas e texto. 4.ed. Rio de Janeiro: McGraw-Hill, 2001.
22. Andressen C, Henseler T. Inheritance of psoriasis. Analysis of 2035 family histories. Hautarzt 1982; 33(4):214-17.
23. Marsal S, Armadans-Gil L, Martínez M, Gallardo D, Ribera A, Lience E. Clinical radiographic and HLA associations as markers for different patterns of psoriatic arthritis. Rheumatology (Oxford) 1999; 38(4):332-7.
24. Sampaio-Barros PD, Azevedo VF, Bonfiglioli R, Campos WR, Carneiro SCS, Carvalho MAP et al. Consenso brasileiro de espondiloartropatias: espondilite anquilosante e artrite psoriásica. Diagnóstico e tratamento - primeira revisão. Rev Bras Reumatol 2007; 47(4):233-42.
25. Antoni CE. Psoriatic arthritis: etiology and pathogenesis. In: Hochber MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH. Rheumatology. 4.ed. Philadelphia: Elsevier, 2008.
26. Rieger A, Chen TM, Cockerell CJ. Cutaneous manifestations of HIV infection and HIV-related disorders. In: Bolognia JL, Jorizzo JL, Rapini RP. Dermatology. 2.ed. Espanha: Elsevier, 2008.
27. Siqueira-Batista R, Gomes AP, Nacif MS, Guerra JEH, Monte-Alto CR, Lima OAT et al. Manifestaçôes reumáticas da síndrome de imunodeficiência adquirida (AIDS). Rev Bras Reumatol 2004; 44(5):339-46.
28. Bruce IN, Silman AJ. The etiology of psoriatic arthritis. Rheumatology (Oxford) 2001; 40(4):363-6.
29. Fortune DG, Main CJ, O'Sullivan TJ, Griffiths CE. Quality of life in patients with psoriasis: the contribution of clinical variables and psoriasis-specific stress. Br J Dermatol 1997; 137(5):755-60.
30. Pattison E, Harrison BJ, Griffiths CE, Silman AJ, Bruce IN. Environmental risk factors for the development of psoriatic arthritis: results from a case-control study. Ann Rheum Dis 2008; 67(5):672-6.
31. Mueller W, Hermann B. Cyclosporin A for psoriasis. N Engl J Med 1979; 301(10):555.
32. Ritchlin CT, Haas-Smith SA, Hicks D, Cappuccio J, Osterland CK, Looney RJ. Patterns of cytokine production in psoriatic synovium. J Rheumatol 1998; 25(8):1544-52.
33. Ritchlin CT. Psoriatic arthritis. Pathology and pathogenesis. In: Klippel JH, Stone H, Crofford LJ, White PH. Primer on the rheumatic diseases. 13.ed. New York: Springer, 2008: 178-84.
34. Helliwell PS, Taylor WJ. Classification and diagnostic criteria for psoriatic arthritis. Ann Rheum Dis 2005; 64(Supl. 2):ii3-8.
35. Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 2006; 54(8):2665-73.
36. Sociedade Brasileira de Dermatologia. Consenso Brasileiro de Psoríase. Rio de Janeiro: SBD, 2009, 116 p.
37. Ciocon DH, Kimball AB. Psoriasis and psoriatic arthritis: separate or one and the same? Br J Dermatol 2007; 157(5):850-60
38. Gladman DD, Antoni C, Mease P, Clegg DO, Nash P. Psoriatic arthritis: epidemiology, clinical features, course and outcome. Ann Rheum Dis 2005; 64(Supl 2): ii14-7.
39. Schatteman L, Mielants H, Veys EM, Cuvelier C, De Vos M, Gyselbrecht L et al. Gut inflammation in psoriatic arthritis: a prospective ileocolonoscopic study. J Rheumatol 1995; 22(4):680-3.
40. McGonagle D, Tan AL, Benjamin M. The nail as musculosketal appendage - implications for an improved understanding of the link between psoriasis and arthritis. Dermatology 2009; 218(2):97-102.
41. Wilson FC, Icen M, Crowson CS, McEvoy MT, Gabriel S, Kremers HM. Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: a population-based study. Arthritis Rheum 2009; 61(2):233-9.
42. Levin J, Werth VP. Skin disorders with arthritis. Best Pract Res Clin Rheumatol 2006; 20(4):809-26.
43. Maksymowych WP. Etiology, pathogenesis and pathology of ankylosing spondylitis. In: Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH. Rheumatology. 4.ed. Philadelphia: Elsevier, 2008.
44. Eastmoond CJ, Woodrow JC. The HLA system and the arthropathies associated with psoriasis. Ann Rheum Dis 1977; 36(2):112-20.
45. Scarpa R, Oriente SP, Pucino A, Torella M, Vignone L, Riccio A et al. Psoriatic arthritis in psoriatic patients. Br J Rheumatol 1984; 23(4):246-50.
46. Jones SM, Armas JB, Cohen MG, Lovell CR, Evison G, McHugh NJ. Psoriatic arthritis: outcome of disease subsets and relationship of joint disease to nail and skin disease. Br J Rheumatol 1994; 33(9):834-9.
47. McGonagle D. Enthesitis: an autoinflammatory lesion linking nail and joint involvement in psoriatic disease. J Eur Acad Dermatol Venereol 2009; 23(Supl 1):9-13.
48. Scarpa R. What do rheumatologists think about psoriatic arthritis today? J Rheumatol 1999; 26(12):2509-10.
49. Scarpa R, Manguso F, D'Arienzo A, D'Armiento FP, Astarita C, Mazzacca G et al. Microscopic inflammatory changes in colon of patients with both active psoriasis and psoriatic arthritis without bowel symptoms. J Rheumatol 2000; 27(5):1241-6.
50. Girolomoni G, Gisondi P. Psoriasis and systemic inflammation: underdiagnosed enthesopathy. J Eur Acad Dermatol Venereol 2009; 23(Supl 1):3-8.
51. Lima EVA. Avaliação do teste T-SPOT. TB no diagnóstico de infecção tuberculosa latente em pacientes com psoríase. São Paulo, 2010. 153 f. [Tese (Doutorado)] - Programa de Dermatologia da Faculdade de Medicina da Universidade de São Paulo, 2010.